Inborn Errors of Adaptive Immunity in Down Syndrome

Area of Science:

• Immunology
• Genetics
• Down Syndrome Research

Background:

• Down syndrome is characterized by an immunophenotype resembling combined immunodeficiency with immune dysregulation.
• Individuals with Down syndrome show increased susceptibility to infections, autoimmunity, autoinflammatory diseases, and hematologic malignancies.
• Both qualitative and quantitative immune alterations are observed, but with significant heterogeneity and no clear clinical correlation.

Purpose of the Study:

• To provide an updated overview of inborn errors of adaptive immunity in Down syndrome.
• To emphasize that immune system differences in Down syndrome are intrinsic from the onset.
• To discuss the role of chromosome 21 gene overexpression and broader genomic dysregulation.

Main Methods:

• Review of existing literature on Down syndrome and immune system function.
• Analysis of genetic factors, specifically gene expression on chromosome 21.
• Comparison with monogenic inborn errors of immunity.

Main Results:

• The immune system in Down syndrome is intrinsically different from the start, not due to premature aging.
• Overexpression of chromosome 21 genes contributes to immune deficiency and dysregulation.
• Trisomy 21 leads to widespread gene dysregulation, creating a complex immune phenotype.

Conclusions:

• Down syndrome presents a unique model of immune dysregulation stemming from genetic factors on chromosome 21.
• Understanding these intrinsic immune differences is crucial for managing associated health risks.
• Further research into adaptive immunity in Down syndrome is warranted.